News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
News
Business
QIAGEN Reports Strong Fourth Quarter and Fiscal 2007 Results
February 12, 2008
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
VENLO, The Netherlands, Feb. 11, 2008 (PRIME NEWSWIRE) -- QIAGEN N.V. (Nasdaq:QGEN) (Frankfurt:QIA) today announced the results of operations for the fourth quarter and the fiscal year ended December 31, 2007.
Twitter
LinkedIn
Facebook
Email
Print
Earnings
Europe
MORE ON THIS TOPIC
Duchenne muscular dystrophy
Sarepta Denies Latest Patient Death is Elevidys-Linked as FDA Launches Probe
July 28, 2025
·
2 min read
·
Tristan Manalac
Collaboration
Eli Lilly Commits $856M in Biobucks to Gate Bioscience for New Class of Medicines
July 25, 2025
·
1 min read
·
Dan Samorodnitsky
Regulatory
Sarepta Fallout Continues With EU’s Negative Opinion of Elevidys in Ambulatory Patients
July 25, 2025
·
2 min read
·
Tristan Manalac
Layoffs
Rocket Trims Headcount and Pipeline Focus Amid Clinical, Regulatory Turbulence
July 25, 2025
·
2 min read
·
Tristan Manalac
